4.7 Article

Discovery of novel histidine-derived lipo-amino acids: Applied in the synthesis of ultra-short antimicrobial peptidomimetics having potent antimicrobial activity, salt resistance and protease stability

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 68, 期 -, 页码 10-18

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2013.07.008

关键词

Histidine-derived amino acid; Antimicrobial peptidomimetics; Salt resistance; Anti-MRSA activity; Protease stability

资金

  1. Korea Basic Science Institute's research grant [T33418, T33518]
  2. National Cancer Institute's Intramural Research grant
  3. Korea Research Foundation
  4. Korean Government [KRF-2011-0009039]

向作者/读者索取更多资源

Here we report for the first time the synthesis of Histidine (His) derived lipo-amino acids having pendant lipid tails at N(tau)- and N(pi)-positions on imidazole group of His and applied it into synthesis of lipo-peptides. The attachment of His-derived lipo-amino acid into the very short inactive cationic peptides endows potent antimicrobial activity against Gram-positive and Gram-negative bacteria without hemolytic activity. Furthermore, our designed His-derived lipo-peptidomimetics (HDLPs) consisting of two or three residues displayed strong anti-MRSA activity and protease stability as well as retained potent antimicrobial activity under high salt concentration. Our results demonstrate that the novel lipo-amino acid is highly flexible to synthesize and carry out the extensive structure activity relationship (SAR) on lipo-antimicrobial peptidomimetics and represents a unique amenable platform for modifying parameters important for antimicrobial activity. Through this study, we proved that the discovery of His-derived lipo-amino acid and the corresponding HDLPs are an excellent candidate as a lead compound for the development of novel antimicrobial agents. (C) 2013 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据